Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstr öm macroglobulinemia.

Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia. Haematologica. 2018 May 17;: Authors: Castillo JJ, Gustine JN, Meid K, Dubeau TE, Xu L, Yang G, Hunter ZR, Advani R, Palomba L, Treon SP PMID: 29773590 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29773590?dopt=Abstract

Source: Haematologica - May 17, 2018 Category: Hematology Authors: Castillo JJ, Gustine JN, Meid K, Dubeau TE, Xu L, Yang G, Hunter ZR, Advani R, Palomba L, Treon SP Tags: Haematologica Source Type: research

More News: Macroglobulinemia | Waldenstrom's Macroglobulinemia